1Johansson P. Epidemiology of the myeloproliferative disorders polycytbemia vera and essential thrombocythemia. Semin Thromb Hemost, 2006, 32: 171-173.
2Ding J, Komatsu H, Wakita A, et al. Familial essential throm- bocyhemia associated with a dominant-positive activating muta- tion of the c-MPL gene, which encodes for the receptor for thromboprotein. Blood, 2004, 103: 4198-4200.
3Baxter E J, Scoh LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 2005, 365: 1054-1061.
4Thiele J, Kvasnicka HM, Orazi A, et al. Essential thrombo- cythemia. // Jaffe ES, Harris NL,Stein H, et al. World Health Organization classification of tumors: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: Lyon IARC Press, 2008: 50-52.
